GoodRx CEO Wendy Barnes outlined the company's priorities at the 2025 JP Morgan Healthcare Conference in San Francisco.

In a large population of people with diabetes, the use of GLP-1 receptor agonists was not linked to an increased risk for ...

A dietetics professor explains who should and should not embrace the latest weight-loss drugs. Holiday weight gain hits home ...

While weight loss is a common new year's resolution for workers in the U.S., 2025 may mark the year that building weight loss ...

Semaglutide combined with automated insulin delivery enhances glucose control in type 1 diabetes, lowering insulin ...

Pharmacy professor Nicole Albanese discusses the science behind drugs like Ozempic and Wegovy, their potential to treat other ...

Australia is home to some truly unique and unexpected creatures, but few are quite as strange and fascinating as the platypus ...

Investors, startups and insurers are promoting individual coverage health reimbursement arrangements, known as ICHRAs, even ...

Scientists uncover how Ffar4 regulates sugar cravings through gut microbiota, revealing pantothenate as a key mediator to ...

Risk for pancreatitis was not elevated among users of tirzepatide relative to placebo, despite the presence of elevated pancreatic enzymes.

BMI falls short as a way to measure obesity. Doctors need to also determine whether body fat harms a person's health.